Consistently, we observed that the expression of GPN3 was related to shorter disease-free survival and overall survival rates among NSCLC patients (Table 2), where high expression levels resulted in reduced disease-free survival rates as well as overall survival rates (Fig. 6F, G). The gene discussed is GPN3; the disease is non-small cell lung carcinoma.